Regional comparison and implications of China's long-term care insurance system / 中国卫生政策研究

This paper attempts to review the long-term care insurance policies which have been issued in 13 national pilot cities such as Qingdao and Haidian district,Beijing. The paper investigates the problems and challen-ges China's long-term care insurance system faces with,and put forward the construction of long-term care insurance system. The preliminary thinking on some issues, such as the relationship between welfare and marketization when the long-term care insurance has been put into practice on a trial basis,the relationship between long-term care insur-ance and medical insurance,and the specific implementation plan of the long-term insurance. According to the issued documents issued by pilot regions,it was found that there are not only differences but also similarities among the pilot cities in who are insured,who pays the insurance fee,what might be covered,what the levels of insurance are,and what kind of service will be provided. Although the long term care insurance system has been initially established in these cities, the specific implementation remains to be demonstrated, e. g. supervision and management, nursing service provision. In addition,local governments need to continuously expand the benefit range of long-term care in-surance to ensure long-term success,do good coordination and connection of long-term care insurance and pension in-surance,and reasonably allocate the medical insurance,pension,and health care resources.

Research on the Institutional Design and Key Issues of Essential Medicine Designated Production / 中国卫生经济

Objective: To analyze the institutional design and key issues of essential medicine designated production. Methods: It analyzed the institutional design and key issues based on theoretical and policy study. Results: The relevant institutional design included coordination and incentive mechanism. But coordination mechanism was short of control to supply activity; the quantity uncertainly weakened the role of incentive mechanism; bulk material, production capacity and supply network made the transaction activity complicated. Conclusion: Government should strengthen the coordination of supply activity , release the uncertainty of essential medicine’s quantity by internet information system, monitor the bulk material’s price and production capacity by the pharmaceutical industry association and reduce the complexity of transaction activity by the intermediate supply.